top of page

Title: Wall St eyes dour open as Omicron worries grow after vaccine warning

  • Writer: analysiswatch
    analysiswatch
  • Nov 30, 2021
  • 2 min read

Nov 30, 2021 08:48AM ET


By: AnalysisWatch


Wall Street's significant lists were set to fall strongly on Tuesday after a notice from the CEO of immunization producer Moderna on the efficacy of the COVID-19 vaccine against the Omicron variant pressured stocks in the travel, energy, and banking sectors.


Worldwide securities exchanges plunged after Moderna CEO Stéphane Bancel told the Financial Times almost certainly, the current age antibody would be changed.


Fears were heightened when Regeneron Pharmaceuticals Inc. said its Coronavirus immunizer treatment and other comparative medications might be less powerful against the Omicron variation.


Occidental Petroleum drove the misfortunes among energy stocks, with its portions falling 3.5% in premarket exchanging, while oil costs drooped almost 3% on-request concerns.


Money Street's enormous loan specialists slipped, following a drop in Treasury yields as a place of refuge request kept security buys high. Bank of America was the biggest loser among public companies, down 2%.


Among aircraft stocks, which fell somewhere in the range of 1.5% and 1.9%, American Airlines Group fell the most. Cruise companies Carnival Corp, Royal Caribbean, and Norwegian Cruise Line each lost about 2 %.


The S&P 500 and the tech-heavy Nasdaq are down 1.9% and 2.7%, respectively, from their record highs, reached earlier this month, while the Dow has fallen 3.9%.


At 10 a.m. ET (1500 GMT), Treasury Secretary Janet Yellen, and Federal Reserve Chairman Jerome Powell will testify before the US Senate Banking Committee at 10 a.m. ET (1500 GMT) to discuss the economic recovery from the pandemic.


In his prepared remarks, Powell said he still expects inflation to fall next year, but warned that the new variant of COVID-19 clouds the outlook, and prices could rise for longer than previously thought.

 
 
 

Comments


2b94f773-a237-4da7-a599-6b42314ed9e6.png

Risk Disclosure: AnalysisWatch will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.
AnalysisWatch would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore AnalysisWatch doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

bottom of page